# Clinical Investigation to Compare the Safety and Efficacy of Cellular Matrix to Those of Ostenil® Plus and to Those of PRP Only

> **NCT02964143** · NA · UNKNOWN · sponsor: **Regen Lab SA** · enrollment: 306 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** Cellular Matrix / A-CP HA
- **DEVICE:** Ostenil® Plus
- **DEVICE:** RegenKit-BCT-1

## Key facts

- **NCT ID:** NCT02964143
- **Lead sponsor:** Regen Lab SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 306 (ESTIMATED)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964143, "Clinical Investigation to Compare the Safety and Efficacy of Cellular Matrix to Those of Ostenil® Plus and to Those of PRP Only". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02964143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*